SAN DIEGO, Jan. 25, 2017 /PRNewswire/ -- Medical Marijuana, Inc. MJNA, +6.62%announced today that its subsidiary Kannaway®, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.
New Kannaway® Gold Premium Hemp Oil is an all-natural, full-spectrum, filtered CBD hemp oil, extracted from the hemp plant and packaged pure with no other ingredients or additives. Each 15-gram tube contains 30 servings for a month's worth of daily CBD. Kannaway® Gold is the company's highest potency product, providing 120mg of CBD per serving and 3600mg of CBD per tube. The new premium hemp oil is decarboxylated to maximize CBD content and put through an additional filtration process to remove the hemp oil's excess waxes, chlorophyll, and plant material, giving the oil its golden color and refined taste.
"We are proud to unveil our newest product to the world," said Kannaway, LLC CEO, Blake Schroeder. "Kannaway® Gold Premium Hemp Oil strives to be the top CBD hemp oil for the range of our consumers. At Kannaway® we go to whatever lengths to see that the needs of our customers are met, because for many this is more than simply a product. Our newest line of hemp oil will continue to push the lengths for satisfaction and nutritional value."
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil .